日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel and safe SmartCap(®) SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans.

一种新型且安全的 SmartCap(®) SC101,用于开发 COVID-19 mRNA 疫苗 STP2104,该疫苗可在人体内诱导强效免疫反应

Kim Rachel, Uhm Tae-Gi, Kim Jisu, Woo Dayeon, Kim Uk-Il, Meng Xue, Yang Byounggu, Kim Suhyeon, Kim Heejene, Kim Jonghyeon, Yoon Sunkyung, Lee Joo-Young, Kim Byungkyun, Cho Dongheon, Chang Duckho, Cho Young-Hwan, Choi Kanghyun, Gwak WonSeok, Lee Hoon-Woo, Bang Jieun, Hellström Elizabeth, Kim Byoungguk, Kim Kyungjin, Yang Joo-Sung

Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method.

利用新型加帽文库筛选方法,发现并开发出安全有效的 COVID-19 mRNA 疫苗 STP2104

Choi Kanghyun, Lee Joo-Young, Kim Uk-Il, Park So-Hyun, Hong So-Hee, Bang Yoo-Jin, Hwang Yun-Ho, Lee Jong-Eun, Park Suhyun, Kim Soochong, Lee Sunhee, Yun Ye-Jin, Uhm Tae-Gi, Lee Inyoung, Kwon Minju, Kwon EunJi, Song Suyeon, Kweon Yongkyoung, Kim Heejene, Oh Eun-Young, Kim Jae-Yong, Lee Tae-Young, Kim Seo-Yeon, Kim Se-Eun, Kim You-Jin, Lee Seonock, Sun Ruijing, Lee Eun-Joo, Kim Gamin, Lim Hanah, Kim Byungkyun, Kim Jungho, Kim Dokeun, Nam Jae-Hwan, Lee Sang-Myeong, Kim Kyungjin, Yang Joo-Sung

A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors

一项针对晚期实体瘤患者的Tankyrase抑制剂Basroparib的首次人体剂量递增I期研究

Lieu, Christopher H; Lenz, Heinz-Josef; Benson, Al B; Meng, Xue; Kim, Uk-Il; Kim, Song Hyun; Kim, Kyungjin; Sung, Moo Je

Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia

抗凝治疗通过缓解缺氧来促进肿瘤免疫微环境的形成,并增强免疫疗法的疗效。

Choi, Jeong Uk; Lee, Na Kyeong; Seo, Hyungseok; Chung, Seung Woo; Al-Hilal, Taslim A; Park, Seong Jin; Kweon, Seho; Min, Nuri; Kim, Sang Kyoon; Ahn, Seohyun; Kim, Uk-Il; Park, Jin Woo; Kang, Chang-Yuil; Kim, In-San; Kim, Sang Yoon; Kim, Kyungjin; Byun, Youngro

A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site

一种高效且安全的吡咯并吡啶类变构HIV-1整合酶抑制剂,靶向宿主LEDGF/p75整合酶相互作用位点。

Maehigashi, Tatsuya; Ahn, Seohyun; Kim, Uk-Il; Lindenberger, Jared; Oo, Adrian; Koneru, Pratibha C; Mahboubi, Bijan; Engelman, Alan N; Kvaratskhelia, Mamuka; Kim, Kyungjin; Kim, Baek